Polomar Health Services (PMHS) Interest Expenses (2023 - 2026)
Polomar Health Services (PMHS) posted Interest Expenses of $18019.0 for Q2 2026, down 2.47% on a QoQ basis from $18475.0 in Q1 2026, and down 57.33% year-over-year from $42230.0 in Q2 2025.
Powered by 
Analysis
Polomar Health Services (PMHS) Interest Expenses (2023 - 2026) Analysis & Trends
Polomar Health Services has reported Interest Expenses for 4 years, with the latest figure at $18019.0 in Q2 2026.
- On a quarterly basis, Interest Expenses fell 57.33% year-over-year to $18019.0 in Q2 2026; TTM through Jun 2026 was $103659.0, a 17.41% decrease from a year earlier, with the FY2025 full-year figure at $150841.0, up 260.54% from the prior year.
- Interest Expenses was $18019.0 for Q2 2026 at Polomar Health Services, down from $18475.0 in the prior quarter.
- The five-year high for Interest Expenses was $46198.0 in Q4 2025, with the low at -$36990.0 in Q4 2023.
- Average Interest Expenses over 4 years is $22966.8, with a median of $25322.0 recorded in 2024.
- The largest YoY upside for Interest Expenses was 180.23% in 2024 against a maximum downside of 67.56% in 2024.
- Over 4 years, Interest Expenses stood at -$36990.0 in 2023, then jumped by 180.23% to $29677.0 in 2024, then jumped by 55.67% to $46198.0 in 2025, then tumbled by 61.0% to $18019.0 in 2026.
- The last three Interest Expenses figures came in at $18019.0 (Q2 2026), $18475.0 (Q1 2026), and $46198.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 120.70 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -13.26 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 396.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -41.02 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 6.66 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 3,000.00 |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | 18,019.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18,019.00 |
| Mar 31, 2026 | 18,475.00 |
| Dec 31, 2025 | 46,198.00 |
| Sep 30, 2025 | 20,967.00 |
| Jun 30, 2025 | 42,230.00 |
| Mar 31, 2025 | 41,447.00 |
| Dec 31, 2024 | 29,677.00 |
| Sep 30, 2024 | 12,160.00 |
| Dec 31, 2023 | -36,990.00 |
| Sep 30, 2023 | 37,485.00 |